Novartis AG (NYSE:NVS) Given Average Recommendation of

3 days ago · Novartis AG (NYSE:NVS - Get Free Report) has earned an average recommendation of "Reduce" from the nine research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell …

$121.50
OFF

Novartis AG (NYSE:NVS) Receives $121.50 Average Price

2 weeks from now

Dec 18, 2024 · Novartis AG (NYSE:NVS - Get Free Report) has been given an average recommendation of "Reduce" by the nine analysts that are covering the stock, Marketbeat.com …

marketbeat.com

$121.50
OFF

Novartis AG (NYSE:NVS) Receives $121.50 Average Target Price …

2 weeks from now

17 hours ago · NVS stock opened at $99.34 on Friday. The business has a fifty day moving average of $101.13 and a 200-day moving average of $109.19. The company has a quick …

etfdailynews.com

$99.27
OFF

Summary - NVS - NYSE - Weiss Ratings

2 weeks from now

Recommendation. Buy. Prev Close. $99.27. Volume. 1,797,306. Avg Vol (90D) 1,135,869. Market Cap. $197.46B. ... Novartis AG (NYSE:NVS) Given Average Recommendation of "Reduce" by …

weissratings.com

$82.25
OFF

Novartis AG (NYSE:NVS) Receives $82.25 Consensus Price Target …

2 weeks from now

Aug 20, 2023 · Shares of Novartis AG (NYSE:NVS – Get Free Report) have been given an average recommendation of “Hold” by the eleven ratings firms that are currently covering the …

americanbankingnews.com

54%
OFF

Novartis AG - ADR (NVS) Price Target Increased By 5.54% To …

2 weeks from now

The average one-year price target for Novartis AG - ADR (NYSE:NVS) has been revised to 115.39 / share. This is an increase of 5.54% from the prior estimate of 109.33 dated June 1, …

nasdaq.com

$2.06
OFF

Novartis (NVS) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

2 days ago · Novartis AG reported a strong quarterly earnings result with an EPS of $2.06, surpassing the consensus estimate of $1.94, showcasing its ability to exceed market …

marketbeat.com

$702000
OFF

Agate Pass Investment Management LLC Invests $702,000 In …

2 weeks from now

2 days ago · Agate Pass Investment Management LLC purchased a new stake in shares of Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent …

marketbeat.com

FAQs about Novartis AG (NYSE:NVS) Given Average Recommendation of Coupon?

Is Novartis AG (NVS) a good stock to buy?

Novartis AG (NYSE:NVS – Get Free Report) has been given a consensus rating of “Reduce” by the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and seven have issued a hold rating on the company. ...

What is the price target for Novartis (NVS)?

The highest price target for NVS is $130.00, while the lowest price target for NVS is $114.00. The average price target represents a forecasted upside of 14.14% from the current price of $106.45. Enter your email address to receive the latest news and analysts' ratings for Novartis and its competitors. ...

What is the forecast for Novartis stock?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Novartis is $121.50, with a high forecast of $130.00 and a low forecast of $114.00. Should I buy or sell Novartis stock right now? ...

Does Novartis AG's price-to-earnings ratio matter?

Novartis AG's price-to-earnings ratio of 15.68 may suggest that the stock is currently trading at a premium valuation, potentially limiting immediate upside for investors. While the company has a strong net margin of 33.76%, any decline in profitability could impact shareholder returns and stock performance. ...

How does Novartis (NVS) compare to other medical companies?

Analysts like Novartis less than other "medical" companies. The consensus rating for Novartis is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NVS compares to other companies. As we enter 2025, digital assets are seeing unprecedented growth and interest. ...

Does Novartis AG's debt-to-equity ratio affect its stock price?

Novartis AG's stock price has experienced fluctuations, with a beta of 0.57, indicating higher volatility compared to the market average. The company's debt-to-equity ratio of 0.47 may raise concerns about its financial leverage and ability to manage debt obligations. ...